Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
Provided By GlobeNewswire
Last update: May 13, 2025
– Company reports $3.4 million in YCANTH revenue, reflective of increasing demand, following the dispensing of more than 10,000 applicator units in the quarter, the most in company history and a 16.7% growth over Q4’24 –
Read more at globenewswire.com
